Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

Fracture incidence after liver transplantation: results of a 10-year audit.

Premaor MO, Das TK, Debiram I, Parker RA, Ninkovic M, Alexander GT, Compston JE.

QJM. 2011 Jul;104(7):599-606. doi: 10.1093/qjmed/hcr025. Epub 2011 Mar 8.

2.

Incidence of vertebral fractures in the first three months after orthotopic liver transplantation.

Ninkovic M, Skingle SJ, Bearcroft PW, Bishop N, Alexander GJ, Compston JE.

Eur J Gastroenterol Hepatol. 2000 Aug;12(8):931-5.

PMID:
10958221
3.

Serial measurements of bone density at the lumbar spine do not predict fracture risk after liver transplantation.

Hardinger KL, Ho B, Schnitzler MA, Desai N, Lowell J, Shenoy S, Chapman W, Crippin JS.

Liver Transpl. 2003 Aug;9(8):857-62.

4.

Low rates of treatment in postmenopausal women with a history of low trauma fractures: results of audit in a Fracture Liaison Service.

Premaor MO, Pilbrow L, Tonkin C, Adams M, Parker RA, Compston J.

QJM. 2010 Jan;103(1):33-40. doi: 10.1093/qjmed/hcp154. Epub 2009 Oct 28.

PMID:
19864348
5.

Better late than never? Experience with intravenous pamidronate treatment in patients with low bone mass or fractures following cardiac or liver transplantation.

Dodidou P, Bruckner T, Hosch S, Haass M, Klar E, Sauer P, Ziegler R, Leidig-Bruckner G.

Osteoporos Int. 2003 Jan;14(1):82-9.

PMID:
12577189
6.

Increased risk of fracture in patients receiving solid organ transplants.

Ramsey-Goldman R, Dunn JE, Dunlop DD, Stuart FP, Abecassis MM, Kaufman DB, Langman CB, Salinger MH, Sprague SM.

J Bone Miner Res. 1999 Mar;14(3):456-63.

7.

Intravenous bisphosphonate prevents symptomatic osteoporotic vertebral collapse in patients after liver transplantation.

Reeves HL, Francis RM, Manas DM, Hudson M, Day CP.

Liver Transpl Surg. 1998 Sep;4(5):404-9.

9.

Lack of effect of intravenous pamidronate on fracture incidence and bone mineral density after orthotopic liver transplantation.

Ninkovic M, Love S, Tom BD, Bearcroft PW, Alexander GJ, Compston JE.

J Hepatol. 2002 Jul;37(1):93-100.

PMID:
12076867
10.

Decreased fracture incidence after 1 year of pamidronate treatment in children with spastic quadriplegic cerebral palsy.

Bachrach SJ, Kecskemethy HH, Harcke HT, Hossain J.

Dev Med Child Neurol. 2010 Sep;52(9):837-42. doi: 10.1111/j.1469-8749.2010.03676.x. Epub 2010 Jun 22.

11.

Population-based study of the effectiveness of bone-specific drugs in reducing the risk of osteoporotic fracture.

Perreault S, Dragomir A, Blais L, Moride Y, Rossignol M, Ste-Marie LG, Fernandès JC.

Pharmacoepidemiol Drug Saf. 2008 Mar;17(3):248-59. doi: 10.1002/pds.1551.

PMID:
18213734
12.

Importance of alfacalcidol in clinical conditions characterized by high rate of bone loss.

Reginster JY, Lecart MP, Richy F.

J Rheumatol Suppl. 2005 Sep;76:21-5.

PMID:
16142847
13.

Fracture risk after parathyroidectomy among chronic hemodialysis patients.

Rudser KD, de Boer IH, Dooley A, Young B, Kestenbaum B.

J Am Soc Nephrol. 2007 Aug;18(8):2401-7. Epub 2007 Jul 18.

14.

The prevention of bone fractures after liver transplantation: experience with alendronate treatment.

Atamaz F, Hepguler S, Karasu Z, Kilic M, Tokat Y.

Transplant Proc. 2006 Jun;38(5):1448-52.

PMID:
16797329
15.

Prolonged-efficacy of bisphosphonate in postmenopausal women with osteoporosis and chronic liver disease.

Arase Y, Suzuki F, Suzuki Y, Akuta N, Kobayashi M, Kawamura Y, Yatsuji H, Sezaki H, Hosaka T, Ikeda K, Kumada H.

J Med Virol. 2008 Jul;80(7):1302-7. doi: 10.1002/jmv.21195. Erratum in: J Med Virol. 2008 Oct;80(10):1868.

PMID:
18461628
16.

Pamidronate in the prevention of bone loss after liver transplantation: a randomized controlled trial.

Monegal A, Guañabens N, Suárez MJ, Suárez F, Clemente G, García-González M, De la Mata M, Serrano T, Casafont F, Tome S, Barrios C, Navasa M.

Transpl Int. 2009 Feb;22(2):198-206. doi: 10.1111/j.1432-2277.2008.00763.x. Epub 2008 Sep 15. Erratum in: Transpl Int. 2009 Jun;22(6):679. Torne, Santiago [corrected to Tome, Santiago].

17.

Long-term fracture risk following renal transplantation: a population-based study.

Vautour LM, Melton LJ 3rd, Clarke BL, Achenbach SJ, Oberg AL, McCarthy JT.

Osteoporos Int. 2004 Feb;15(2):160-7. Epub 2003 Dec 9.

PMID:
14666400
18.

Osteoporosis after liver transplantation.

Compston JE.

Liver Transpl. 2003 Apr;9(4):321-30. Review.

19.

Bone densitometry should be included in the evaluation of candidates for lung transplantation.

Dodd VA, Staron RB, Papadopoulos A, Evans L, Schulman LL, Jorgensen B, Gerow-Smith R, Shane E.

J Transpl Coord. 1999 Jun;9(2):119-23.

PMID:
10703394
20.

The impact of teriparatide adherence and persistence on fracture outcomes.

Yu S, Burge RT, Foster SA, Gelwicks S, Meadows ES.

Osteoporos Int. 2012 Mar;23(3):1103-13. doi: 10.1007/s00198-011-1843-3. Epub 2011 Dec 8.

PMID:
22159748

Supplemental Content

Support Center